From clinical proof-of-concept to commercialization of CAR T cells.

Calmels, Boris; Mfarrej, Bechara; Chabannon, Christian

Calmels, Boris; Mfarrej, Bechara; Chabannon, Christian.

Afiliación

Calmels B; CBT-1409: INSERM, Aix Marseille Univ, Institut Paoli-Calmettes, AP-HM, Marseille, France; Cell Processing and Cell Collection Facility/Tissue Establishment, Institut Paoli-Calmettes, Marseille, France.
Mfarrej B; CBT-1409: INSERM, Aix Marseille Univ, Institut Paoli-Calmettes, AP-HM, Marseille, France; Cell Processing and Cell Collection Facility/Tissue Establishment, Institut Paoli-Calmettes, Marseille, France.
Chabannon C; CBT-1409: INSERM, Aix Marseille Univ, Institut Paoli-Calmettes, AP-HM, Marseille, France; Cell Processing and Cell Collection Facility/Tissue Establishment, Institut Paoli-Calmettes, Marseille, France; EBMT Cell Therapy & Immunobiology Working Party. Electronic address: chabannonc@ipc.unicancer.fr.

Drug Discov Today ; 23(4): 758-762, 2018 Apr.

Article en En | MEDLINE | ID: mdl-29317339

Asunto(s)

Receptores de Antígenos de Linfocitos T/metabolismo; Linfocitos T/fisiología; Animales; Ensayos Clínicos como Asunto; Hospitales; Humanos; Industrias; Linfocitos T/metabolismo

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Linfocitos T Límite: Animals / Humans Idioma: En Revista: Drug Discov Today Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2018 Tipo del documento: Article País de afiliación: Francia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google